is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) (NCT01908556) | Institut fuer Frauengesundheit | 2009-02-01 |
Track is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. automatically
Every clearance here is in the API, with alerts when new ones post.